This is the authors' abstract. We don't add key points for this paper.
Background Biologics are the important drugs for severe asthma, but clinical trials included few elderly patients. Data on the safety and efficacy of benralizumab in elderly asthma patients are limited.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Somekawa et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: